Dose-Response Effects of Mindfulness Meditation
Condition(s) studied
Investigational drug(s) / intervention(s)
Mindfulness meditation guided practice: Participants will listen to recordings of mindfulness meditation practices from a newly developed 28-day program.
Study summary
The goal of this randomized controlled trial is to test for evidence of dose-response effects in a sample of healthy adults with little to no prior experience with meditation.
The main question it aims to answer is whether larger doses of mindfulness meditation yield greater positive changes in wellbeing than smaller doses.
Our hypotheses are that (1) larger doses of mindfulness training will yield significantly larger effects, and (2) different doses will be significantly associated with variation in participant engagement, with lower engagement associated with higher doses.
Researchers will compare each of three dose conditions, 10-min, 20-min, 30-min, against a minimal dose condition of 3-4 min.
Participants will take a 28-day mindfulness meditation course, with guided audio instructions provided daily throughout the intervention period (excluding one rest day per week). They will also be asked to respond to surveys before, during, and after the intervention.
Eligibility
Primary outcome measure(s)
- Psychological wellbeing — Baseline, Post-intervention (4 weeks), Follow-up (8 weeks)
Psychological well-being will be assessed using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), which includes 14 positively worded items of mental well-being for the past 2-weeks, on a 5-point Likert scale from 1 (None of the time) to 5 (All of the time).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Contemplative Studies Centre, The University of Melbourne | Carlton | Victoria | Recruiting |
More University of Melbourne trials in Australia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06378450 on ClinicalTrials.gov ↗ ← All trials in Australia